How do doctors want to engage with pharma on new products?
Debates & Insight
With more than 80 per cent of European doctors saying they want to stay abreast of new developments about pharmaceutical products, it is important to understand how they wish to receive this information.
A survey by M3 Global Research of over 1,800 doctors from the top five EU countries and beyond has consolidated their thinking and finds that they value pharma's contribution. In fact, 72 per cent say the industry's delivery of new medicines will be the main factor helping to improve the outlook for their patients over the next three years.
Download the White Paper now to discover how doctors are accessing the latest developments about medicines and their preferred ways of receiving promotional material.
